I agree that this site is using cookies. You can find further informations here.
X
MISHIMA, Yuko
190  results:
Search for persons X
?
1

Complex karyotype determined using conventional cytogenetic..:

Uryu, Hideki ; Mishima, Yuko ; Ishihara, Yuko...
Journal of Clinical and Experimental Hematopathology.  64 (2024)  1 - p. 10-20 , 2024
Link: https://doi.org/10.3960/..
 
?
2

Antithrombin supplementation attenuates heparin resistance ..:

Mishima, Yuko ; Butt, Amir L. ; Vandyck, Kofi B....
British Journal of Anaesthesia.  132 (2024)  6 - p. 1204-1210 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Heparin Resistance after Andexanet Alfa – Calling on Argatr..:

Mishima, Yuko ; Okada, Hisako ; Butt, Amir L..
Journal of Cardiothoracic and Vascular Anesthesia.  , 2024
Link: https://doi.org/10.1053/..
 
?
4

Dose-escalation part of Phase I study of single-agent mosun..:

Munakata, Wataru ; Izutsu, Koji ; Mishima, Yuko...
Japanese Journal of Clinical Oncology.  53 (2023)  10 - p. 912-921 , 2023
Link: https://doi.org/10.1093/..
 
?
5

Eosinophil‐rich variant of nodal marginal zone lymphoma: a ..:

Miyake, Misayo ; Sakata, Seiji ; Tsuyama, Naoko...
Histopathology.  83 (2023)  3 - p. 443-452 , 2023
Link: https://doi.org/10.1111/..
 
?
6

P1086: EFFICACY AND SAFETY OF ZANDELISIB ADMINISTERED BY IN..:

Kumode, Takahiro ; Munakata, Wataru ; Goto, Hideki...
HemaSphere.  7 (2023)  S3 - p. e72498b6 , 2023
Link: https://doi.org/10.1097/..
 
?
7

Prognostic value of post-treatment serum soluble interleuki..:

Shirouchi, Yuko ; Nishimura, Noriko ; Mishima, Yuko...
Scientific Reports.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
8

Safety, pharmacokinetics, and efficacy of belantamab mafodo..:

Iida, Shinsuke ; Sunami, Kazutaka ; Mishima, Yuko...
International Journal of Hematology.  118 (2023)  5 - p. 596-608 , 2023
Link: https://doi.org/10.1007/..
 
?
9

In vitro effects of Gla-domainless factor Xa analog on proc..:

Terada, Rui ; Johnson, Penny M. ; Butt, Amir L....
Thrombosis Research.  230 (2023)  - p. 119-125 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Subcutaneous epcoritamab monotherapy in Japanese adults wit..:

Izutsu, Koji ; Kumode, Takahiro ; Yuda, Junichiro...
Cancer Science.  114 (2023)  12 - p. 4643-4653 , 2023
Link: https://doi.org/10.1111/..
 
?
11

P1106: CLINICAL OUTCOME OF PATIENTS WITH LOCALIZED PRIMARY ..:

Hirano, Kei ; Yoshida, Kikuaki ; Inoue, Norihito...
HemaSphere.  7 (2023)  S3 - p. e64794e6 , 2023
Link: https://doi.org/10.1097/..
 
?
12

PB2317: POLATUZUMAB VEDOTIN PLUS BENDAMUSTINE AND RITUXIMAB..:

Hirano, Mitsuhito ; Yoshida, Kikuaki ; Hirano, Kei...
HemaSphere.  7 (2023)  S3 - p. e3121335 , 2023
Link: https://doi.org/10.1097/..
 
?
13

Japanese phase Ib study of the oral PI3K-δ and -γ inhibitor..:

Makita, Shinichi ; Ota, Shuichi ; Mishima, Yuko...
International Journal of Hematology.  119 (2023)  2 - p. 156-163 , 2023
Link: https://doi.org/10.1007/..
 
?
14

Serum cell-free DNA concentration as a possible prognostic ..:

SHIROUCHI, Yuko ; MISHIMA, Yuko ; TAKAYAMA, Tomoko...
Biomedical Research.  43 (2022)  4 - p. 99-106 , 2022
Link: https://doi.org/10.2220/..
 
?
15

Zandelisib (ME-401) in Japanese patients with relapsed or r..:

Goto, Hideki ; Izutsu, Koji ; Ennishi, Daisuke...
International Journal of Hematology.  116 (2022)  6 - p. 911-921 , 2022
Link: https://doi.org/10.1007/..
 
1-15